Results 1 to 10 of about 89 (85)
Neuronal ceroid lipofuscinosis type 2 (CLN2 disease) is a rare, autosomal recessive neurodegenerative disorder caused by mutations in the TPP1 gene, which lead to a decrease or complete loss of lysosomal tripeptidyl peptidase 1 enzyme activity. The classic form of CLN2 disease typically manifests between the ages of 2 and 4 years. Over time, there is a
Svetlana V. Mikhaylova +3 more
openaire +1 more source
Atypical neuronal ceroid lipofuscinosis type 2 disease (CLN2): a case report
Mariana Braga Valadão +5 more
openaire +1 more source
AbstractThe neuronal ceroid lipofuscinosis type 2 (CLN2) is a heterogeneous group of neurodegenerative lysosomal storage disorders caused by autosomal recessive inheritance of two pathogenic variants in trans in the TPP1 gene. Classical late‐infantile CLN2 disease has a very well‐defined natural history.
Nataliia Olkhovych +11 more
openaire +4 more sources
Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2
Serdaroğlu, Esra +13 more
openaire +1 more source
First case of use of cerliponase alfa in a child with neuronal ceroid lipofuscinosis type 2 in Bahia
Érica Otoni Pereira Miranda +8 more
openaire +1 more source
Some of the next articles are maybe not open access.
Photosensitivity Is an Early Marker of Neuronal Ceroid Lipofuscinosis Type 2 Disease
Epilepsia, 2017SummaryObjectiveThis study aimed to identify early clinical, magnetic resonance imaging (MRI), and electroencephalographic (EEG) characteristics of neuronal ceroid lipofuscinosis type 2 (CLN2) disease to enable early diagnosis, thus providing the key to early treatment, and optimized care and outcomes.MethodsRetrospective clinical chart review of a ...
Federico Vigevano +2 more
exaly +3 more sources
Cynomolgus macaque model of neuronal ceroid lipofuscinosis type 2 disease
Experimental Neurology, 2023Neuronal ceroid lipofuscinoses (NCLs) are autosomal-recessive fatal neurodegenerative diseases that occur in children and young adults, with symptoms including ataxia, seizures and visual impairment. We report the discovery of cynomolgus macaques carrying the CLN2/TPP1 variant and our analysis of whether the macaques could be a new non-human primate ...
Yoshiko, Munesue +12 more
openaire +2 more sources

